SOPHiA GENETICS
Contact Us

How should capture libraries be diluted for loading on the Thermo Fisher Scientific Ion S5™ System?

A

How should capture libraries be diluted for loading on the Thermo Fisher Scientific Ion S5™ System?

Library pool(s) can be diluted in water to reach the recommended final concentration for sequencing: 100pM for the One Touch 2 System, or 75pM for the Ion Chef System.

logo footer
Platform

Technology
Genomics
Radiomics
Multimodal

Clinical

Oncology
Rare and Inherited Diseases
Cardiology
Neurology
Metabolism

BioPHARMA

BioPharma

RESOURCES

Publications
Case Studies

Company

About Us
Team
Investors
Blog, News & Events
Careers
Contact
Press Kit

© 2021 SOPHiA GENETICS. All rights reserved. Privacy Policy | Terms of Use | Legal

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA Hereditary Cancer Solution, SOPHiA Myeloid Solution, SOPHiA Solid Tumor Solution are available as CE-IVD product for In Vitro Diagnostic Use in Europe, Turkey and Israel. Information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

Somatic gene variant annotations and related content have been powered by, without limitation, The Jackson Laboratory Clinical Knowledgebase (JAX-CKB™).

SOPHiA GENETICS
Platform

Technology
Genomics
Radiomics
Multimodal

Clinical

Oncology
Rare and Inherited Diseases
Cardiology
Neurology
Metabolism

BioPHARMA

BioPharma

Resources

Publications
Case Studies

Company

About Us
Team
Investors
Blog, News & Events
Careers
Contact
Press Kit

© 2021 SOPHiA GENETICS. All rights reserved.
Privacy Policy | Terms of Use | Legal

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA Hereditary Cancer Solution, SOPHiA Myeloid Solution, SOPHiA Solid Tumor Solution are available as CE-IVD product for In Vitro Diagnostic Use in Europe, Turkey and Israel. Information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

Somatic gene variant annotations and related content have been powered by, without limitation, The Jackson Laboratory Clinical Knowledgebase (JAX-CKB™).